Cargando…
Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
Background: Cholangiocarcinoma has obvious primary multidrug resistance and is generally resistant to cisplatin and other chemotherapy drugs and high glycolytic levels may be associated with chemotherapy resistance of cholangiocarcinoma cells. Dichloroacetate (DCA) is a specific inhibitor of PDK, wh...
Autores principales: | Qin, Hanjiao, Zheng, Ge, Li, Qiao, Shen, Luyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560739/ https://www.ncbi.nlm.nih.gov/pubmed/37818192 http://dx.doi.org/10.3389/fphar.2023.1128312 |
Ejemplares similares
-
Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS
por: Qu, Xianzhi, et al.
Publicado: (2017) -
Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest
por: Han, Bingjie, et al.
Publicado: (2022) -
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
por: Michelakis, E D, et al.
Publicado: (2008) -
Metabolic reprogramming of pulmonary fibrosis
por: Li, Jiaxin, et al.
Publicado: (2022) -
Protective effects of mitochondrial fission inhibition on ox-LDL induced VSMC foaming via metabolic reprogramming
por: Fang, Yijin, et al.
Publicado: (2022)